Have a personal or library account? Click to login
Bdellovibrio bacteriovorus: More than Just a Bacterial Hunter Cover

Bdellovibrio bacteriovorus: More than Just a Bacterial Hunter

Advancements of Microbiology
Volume 61 (2022): Issue 4 (December 2022)
By:
Open Access
|Nov 2022

Figures & Tables

Fig. 1

(Adapted from “The Role of ILC2s in Asthma Pathogenesis”, by BioRender.com (2022). Retrieved from https://app.biorender.com/biorender-templates)Description: A visual representation of the type of research conducted in the last decade concerning B. bacteriovorus. The review uses studies from the following areas to establish the antibacterial properties of the predator. 1a) The features of predation highlighted by the studies from the last decade provide new insight into the predation process. Followed by the 1b) In-vitro testing of the species to establish B. bacteriovorus as non-cytotoxic toward human cell lines and effective in preying on known gram-negative pathogens. Moreover, using this information to conduct 1c) In-vivo animal studies to test whether the knowledge gained from in-vitro studies translates well in animals. But also, to use a mammalian model in mice to study the predator’s safety to gain some idea of its efficacy in humans. Lastly, 1d) Industrial applications provide a different perspective on B. bacteriovorus. As its ability to prey on gram-negative species is put to use in various commercial settings. Ranging from its role in the food industry, it can prevent spoilage from gram-negative species like E. coli. To a more sophisticated field like Biotechnology, using its hydrolytic enzymes, it can obtain hard-to-extract biopolymers like polyhydroxyalkanoates (PHAs) from the cytoplasm of gram-negative bacteria. Adding to the reputation of B. bacteriovorus for being efficacious against gram-negative bacteria and being multifaceted. With most of the reviewed studies suggesting the use of this species as an antibiotic replacement, substantial evidence to merit the safety of this predator as an antimicrobial agent in humans is still missing. There are other areas of B. bacteriovorus, including its genome, that have received considerable attention in the last decade but lie beyond the scope of this review.
(Adapted from “The Role of ILC2s in Asthma Pathogenesis”, by BioRender.com (2022). Retrieved from https://app.biorender.com/biorender-templates)Description: A visual representation of the type of research conducted in the last decade concerning B. bacteriovorus. The review uses studies from the following areas to establish the antibacterial properties of the predator. 1a) The features of predation highlighted by the studies from the last decade provide new insight into the predation process. Followed by the 1b) In-vitro testing of the species to establish B. bacteriovorus as non-cytotoxic toward human cell lines and effective in preying on known gram-negative pathogens. Moreover, using this information to conduct 1c) In-vivo animal studies to test whether the knowledge gained from in-vitro studies translates well in animals. But also, to use a mammalian model in mice to study the predator’s safety to gain some idea of its efficacy in humans. Lastly, 1d) Industrial applications provide a different perspective on B. bacteriovorus. As its ability to prey on gram-negative species is put to use in various commercial settings. Ranging from its role in the food industry, it can prevent spoilage from gram-negative species like E. coli. To a more sophisticated field like Biotechnology, using its hydrolytic enzymes, it can obtain hard-to-extract biopolymers like polyhydroxyalkanoates (PHAs) from the cytoplasm of gram-negative bacteria. Adding to the reputation of B. bacteriovorus for being efficacious against gram-negative bacteria and being multifaceted. With most of the reviewed studies suggesting the use of this species as an antibiotic replacement, substantial evidence to merit the safety of this predator as an antimicrobial agent in humans is still missing. There are other areas of B. bacteriovorus, including its genome, that have received considerable attention in the last decade but lie beyond the scope of this review.

Fig. 2

(Adapted from “Lytic and Lysogenic Cycle”, by BioRender.com (2022). Retrieved from https://app.biorender.com/biorender-templates)Description: The life cycle of the predatory, gram-negative bacterial species B. bacteriovorus. The life cycle is divided into an Attack Phase (AP) and a Growth Phase (GP). AP: (1. Predator searches for and locates its prey (a gram-negative bacterial host) using chemotaxis followed by swimming towards the prey using its flagellum. 2. B. bacteriovorus, upon finding its prey, attaches to its cell wall). GP: (3. Predator uses its massive arsenal of hydrolytic enzymes to enter the prey cell and feed on the prey cell cytoplasm using hydrolases. The host cell is now called a bdelloplast. 4. The predator grows and forms a polynucleoid filament, almost the size of the prey cell itself. 5. Filament undergoes septation. 6. A new line of AP cells is released. 7. The bdelloplast peptidoglycan undergoes deacetylation by the newly formed AP cells. Thus, they are released. And the cycle repeats itself [14, 23, 36, 40, 53, 63, 67, 68].
(Adapted from “Lytic and Lysogenic Cycle”, by BioRender.com (2022). Retrieved from https://app.biorender.com/biorender-templates)Description: The life cycle of the predatory, gram-negative bacterial species B. bacteriovorus. The life cycle is divided into an Attack Phase (AP) and a Growth Phase (GP). AP: (1. Predator searches for and locates its prey (a gram-negative bacterial host) using chemotaxis followed by swimming towards the prey using its flagellum. 2. B. bacteriovorus, upon finding its prey, attaches to its cell wall). GP: (3. Predator uses its massive arsenal of hydrolytic enzymes to enter the prey cell and feed on the prey cell cytoplasm using hydrolases. The host cell is now called a bdelloplast. 4. The predator grows and forms a polynucleoid filament, almost the size of the prey cell itself. 5. Filament undergoes septation. 6. A new line of AP cells is released. 7. The bdelloplast peptidoglycan undergoes deacetylation by the newly formed AP cells. Thus, they are released. And the cycle repeats itself [14, 23, 36, 40, 53, 63, 67, 68].
DOI: https://doi.org/10.2478/am-2022-018 | Journal eISSN: 2545-3149 | Journal ISSN: 0079-4252
Journal RSS Feed
Language: English, Polish
Page range: 169 - 178
Submitted on: May 1, 2022
Accepted on: Sep 1, 2022
Published on: Nov 30, 2022
Published by: Polish Society of Microbiologists
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
antimicrobial,
gram-negative,
live antibiotic,
predatory species
Related subjects:
Life sciences,
Microbiology and virology

© 2022 Tayyab Saleem, Muhammad Ishfaq, Muhammad Faheem, Syed Babar Jamal, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 61 (2022): Issue 4 (December 2022)Next article